当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析

欧林生物

(688319)

  

流通市值:111.04亿  总市值:111.19亿
流通股本:4.05亿   总股本:4.06亿

欧林生物(688319)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.47亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益96833.83万元,未分配利润-4841.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产194496.96万元,负债97663.13万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入506,920,470.94305,849,689.8287,490,281.98588,858,464.45
营业总成本440,264,661.39267,455,854.27103,562,135.21569,996,827.89
其他经营收益
营业利润55,605,554.7314,691,495.92-7,043,237.1521,310,232.61
利润总额55,750,565.2614,682,785.21-7,041,533.3422,303,700.36
净利润47,148,308.4413,229,790.42-7,041,533.3415,720,687.32
每股收益
其他综合收益----
综合收益总额47,148,308.4413,229,790.42-7,041,533.3415,720,687.32
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计964,223,718.56908,203,566.45864,478,590.71908,143,768.42
非流动资产:
非流动资产合计980,745,921.32928,030,524.41909,551,607.5898,899,641.1
资产总计1,944,969,639.881,836,234,090.861,774,030,198.211,807,043,409.52
流动负债:
流动负债合计632,389,342.18562,784,387.37538,296,579.93595,593,540.91
非流动负债:
非流动负债合计344,241,955.21339,029,879.02307,363,891.91277,947,646.99
负债合计976,631,297.39901,814,266.39845,660,471.84873,541,187.9
所有者权益(或股东权益):
归属于母公司股东权益合计959,846,714.83925,563,838.32919,514,260.73924,679,134.42
股东权益合计968,338,342.49934,419,824.47928,369,726.37933,502,221.62
负债和股东权益合计1,944,969,639.881,836,234,090.861,774,030,198.211,807,043,409.52
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计440,054,821.11249,294,781.17111,698,403.04535,740,939.88
经营活动现金流出小计407,009,586.17269,033,461.69135,202,278.46545,472,150.28
经营活动产生的现金流量净额33,045,234.94-19,738,680.52-23,503,875.42-9,731,210.4
投资活动产生的现金流量:
投资活动现金流入小计95,287,167.135,178,242.4415,070,592.05219,885,077.26
投资活动现金流出小计192,769,448.6974,368,914.0838,488,849.27443,819,279.08
投资活动产生的现金流量净额-97,482,281.59-39,190,671.64-23,418,257.22-223,934,201.82
筹资活动产生的现金流量:
筹资活动现金流入小计125,000,00095,000,00045,000,000206,823,147
筹资活动现金流出小计115,053,727.5575,909,320.7930,761,216.24110,915,776.95
筹资活动产生的现金流量净额9,946,272.4519,090,679.2114,238,783.7695,907,370.05
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-54,490,774.2-39,838,672.95-32,683,348.88-137,758,042.17
期末现金及现金等价物余额163,286,056.81177,938,158.06185,093,482.13217,776,831.01
补充资料:
现金及现金等价物的净增加额--39,838,672.95--137,758,042.17
最新报告期:2025-11-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘若飞,贺菊颖0.170.200.232025-11-26
华安证券谭国超0.130.150.182025-11-18
国投证券胡雨晴0.170.200.242025-11-04
西南证券杜向阳0.180.110.142025-10-31
中信建投刘若飞,贺菊颖0.080.130.182025-09-17
TOP↑